| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0048681766467277 | 0.31127794 |
| NSC 13484 | Null | 0.0048681766467277 | 0.23299141 |
| NSC 144163 | Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- | 0.0048681766467277 | 0.42992314 |
| NSC 354051 | LISCUNDITRIN | 0.0048681766467277 | 0.20807305 |
| NSC 375162 | Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide | 0.0048681766467277 | 0.057765806 |
| NSC 601679 | Null | 0.0048681766467277 | 0.20037908 |
| NSC 603084 | 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- | 0.0048681766467277 | 0.41526674 |
| NSC 618770 | Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide | 0.0048681766467277 | 0.28318111 |
| NSC 623723 | Null | 0.0048681766467277 | 0.16844097 |
| NSC 632573 | Tris(1,3-diphenylpropane-1,3-dionata)gallium(III) | 0.0048681766467277 | 0.15925143 |